High-Dose Statins Increase Adverse Events and Do Not Improve Survival

J Am Coll Cardiol. 2022 Oct 18;80(16):e125. doi: 10.1016/j.jacc.2022.06.045.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cardiovascular Diseases*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors